CURRICULUM VITAE
Personal information : Location Tehran , Iran. Tel.:0098 912 1940902 Offices:
1- Clinical Pharmacy Department, School of Pharmacy, Sahhid Beheshti University of Medical
Sciences, Niayesh & Vali e Asr intercept, Opposite to Goharbin jewlery
2- Pharmaceutical Care Department, Masih Daneshvari Hospital, Beheshti University of Medical
Telefax: 26109503 E-mail: [email protected] and
Date of Birth: Sep. 22, 1971 Education/Degree
Research Fellowship in Diabetes, Tulane Med. Center, New Orleans, LA, USA.
Residency Training Program, Tehran University of Medical Sciences, Faculty of Pharmacy, Iran.
Doctor of Pharmacy, Pharm. D. Tehran University of Medical Sciences, Faculty of Pharmacy, Iran.
Licensure
¾ Pharmcy Licenses
• Iranian Board Certified Pharmacotherapy Specialist (BCPS) • Clinical Pharmacy Practitioner (Pharm. D.)
• Registered Pharmacist (Iranian Medical Council ID :D-5185)
¾ Other Professional Licenses
• Training course on Pharmacovigilance,Uppsala- Sweden, 12-23 May 2003
• Drug & Therapeutic Committees (DTC) & Training of Trainers (TOT) Course, ﺰﻳاﻮﺟ
1386 لﺎﺳ رد هﺎﮕﺸﻧاد ﻲﻤﻠﻋ تﺄﻴﻫ ﺐﺨﺘﻨﻣ ﺮﮕﺸﻫوﮋﭘ يرﻮﺸﻧاد ﺢﻴﺴﻣ ﺰ ﻛﺮﻣ رد 1388 لﺎﺳ رد ﻪﻧﻮﻤﻧ ﻲﻤﻠﻋ تﺄﻴﻫ يﺮﻬﻄﻣ ﺪﻴﻬﺷ ﻲﺷزﻮﻣآ راﻮﻨﺸﺟ ﻦﻴﻣﻮﺳ ردرﻮﺸﻛ رد ﺮﺗﺮﺑ ﻲﺷزﻮﻣآ ﺪﻨﻳآﺮﻓ هﺪﻧﺮﺑ Professional & Clinical Experiences
Board of Clinical Pharmacy Dec 2008- present Position: Secretary of Board of Clinical Pharmacy Pharmaceutical Care Department, Masih Daneshvari Hospital: National Research Institute of Tuberculosis and Lung Disease (NRITLD) Aug 2004- present Shahid Beheshti Medical University, Tehran, Iran. Position: Head of Pharmaceutical Care Department Services and activities: Clinical pharmacy section is staffed by: * Clinical pharmacy specialists (Pharmacotherapists) * Pharmacologists * Pharmacists Consistent with the mission of the department of Clinical Pharmacy (Pharmacotherapy), located in Pharmacy School, programs focus on activities that contribute directly to professional and scientific works resulting in advancement of practice, safety, education and optimizing drug therapy in the hospital. The activities are listed below: 1. Anticoagulation management services (inpatient and out patient) 2. Drug safety (drug - related morbidity, adverse drug reaction, dose individualization, interaction, special patient population monitoring, medication errors, .) 3. Management and strategy (implementing management strategy in hospital pharmacy, reengineering of services to meet new demands, addressing leadership questions .) 4. Drug information (drug information on a specific disease, development in information delivery .) 5. Clinical Pharmacy (intervention, patient specific pharmacotherapy, outcome assessment .) 6. Hospital pharmacy practice (formulary management, DTC IV admixture) 7. Monthly ADR bulletin (mainly devoted to interesting cases detected in the hospital) 8. Clinical pharmacokinetics (Calculation, TDMs, .) 9. Clinical pharmacy researches (mostly designed to result in optimal pharmaceutical care) 10. Pharmacy student and clinical pharmacy resident education 11. Basic pharmacological researches aimed at investigating cellular mechanism of drug handling and toxicity(e.g. polymorphism) 12. Pharmacoeconomy (DUR, Quality of life, Cost-effectiveness, CMA .) 13. Drug protocols and treatment guidelines : establishment, implementation and evaluation. Community Pharmacy Externship Course Coordinator & Instructor Faculty of Pharmacy, Shaheed Beheshti Medical University, Tehran, Iran. June 2000-2003 Drug Information Course Coordinator & Instructor Faculty of Pharmacy, Shaheed Beheshti Medical University, Tehran, Iran. Sep. 1999-2002
Pharmacy Consultant Tehran Emergency Building, Poison Information Center Feb. 1999- Feb. 2001 Vice Pharmacy Consultant Dubai Iranian Hospital Aug. 2000- Sep. 2000 Medical Rep.(Product Specialist) Glaxo-Welcome Pharmaceutical Company (Tehran office: Jahan Behbood) Feb. 1998- Apr. 1998 (Quited to start residency program) Staff Pharmacist Polyclinic Pharmacy Imam Khomeini General Hospital May 1997-May 1998 Pharmacy Manager Pediatric Amirkabir Hospital June 1995-May 1997 Publications:
1. Fahimi F, Moradi M, Safarnavadeh T, Namdar R. Review of the management of
community acquired pneumonia in a teaching hospital: assessment of the role of established guidelines. Tanaffos. Oct. 2007;6(2): 35-40
2. Fahimi F, Baniasadi S, Malekmohammad M. Neurologic and Psychotic Reaction
Induced by Lidocaine. Journal of Bronchology 2007;14(1):57-8
3. Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting
system at a teaching hospital. Basic Clin Pharmacol Toxicol. 2008; 102(4):408-11
4. Fahimi F, Sistanizad M, Abrishami R, Baniasadi S. An observational study of
errors related to the preparation and administration of medications given by infusion devices in a teaching hospital. Iranian J Pharm Res 2007;6(4): 295-9
5. Fahimi F, Ariapanah P, Faizi M, Shafaghi B, Namdar R, Tavakoli Ardakani M.
Errors in preparation and administration of intravenous medications in the
intensive care unit of a teaching hospital: an observational study. Aust Crit Care. 2008 May; 21(2):110-6
6. Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting
system at a teaching hospital. Basic Clin Pharmacol Toxicol. 2008; 102(4):408-11
7. Fahimi F, Baniasadi S, Amini S. Adverse drug reactions in the post coronary care
unit inpatients of a teaching hospital. Iranian J Pharm Res 2008;7(3): 223-8
8. Fahimi F, Abbasi Nazari M, Abrishami R, Sistanizad M, Mazidi T, Faghihi T,
Soltani R, Baniasadi S. Transcription errors observed in a teaching hospital. Arch Iran Med 2009;12(2):173-5
9. Baniasadi S, Fahimi F, Namdar R. Development of an adverse drug reaction
bulletin in a teaching hospital. Formulary 2009; 44:333-5.
10. Fahimi F, Baniasadi S, Najafizadeh K. Does switch to another dosage form of
Neoral increase the risk of medication error? Ann Transplant 2009;14(4):58-60
11. Fahimi F, Salamzadeh J, Jamaati HR, Sohrabi S, Fakharian A, Mohammadtaheri
Z. Do statins improve lung function in asthmatic patients? A randomized and double-blind trial. IJPS, 2009; 5(1): 13-20
12. Baghaei P, Tabarsi P, Chitsaz E, Saleh M, Marjani M, Shemirani S, Pooramiri
MV, Kazempour M, Farnia P, Fahimi F, Mansouri D, Masjedi M. Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases. Am J Ther. 2010;17(1):17-22
13. Dezfouli AA, Najafizadeh K, Parsa T, Shadmehr MB, Dabir S, Mohammadi F,
Tabarsi P, Lankarani MM, Assari S, Marjani M, Fahimi F, Shafaghi S, Faeghi J, Masjedi MR. Postlung transplant rehospitalization: a study of causes, health care burden, and outcomes. Exp Clin Transplant. 2009 Sep;7(3):192-6
14. Baniasadi S, Beizaee S, Kazemi B, Behzadnia N, Shafaghi B, Bandehpour M,
Fahimi F. Novel VKORC1 Mutations Associated with Warfarin Sensitivity. Cardiovasc Ther. 2010. [Epub ahead of print]
15. Baniasadi S, Eftekhari P, Tabarsi P, Fahimi F, Raoufy MR, Masjedi MR,
Velayati AA. Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity. Eur J Gastroenterol Hepatol. 2010. [Epub ahead of print]
16. Fahimi F. Implementation of a clinical pharmacy education program: Resident
oriented documentation and intervention. Iranian J Pharm Res (In press)
17. Tavallaee , Fahimi F, Kiani S, Drug use patterns in an Intensive Care Unit of a
hospital in Iran: an observational prospective study. International Journal of Pharmacy Practice. (In Press)
Submitted manuscripts
Fahimi F, Kobarfard F, Tabarsi P, Hemmati S, Baniasadi S, Salamzadeh J, Isoniazid blood levels in patients with pulmonary tuberculosis at a tuberculosis referral center. Chemotherapy. (Responded to review) Fahimi F, Amini S, Khodadad K, Naghibi F, Salamzadeh J, Baniasadi S. Evaluation of the effect of zingiber officinalis on nausea and vomiting in patients receiving cisplatin based regimens Alternative and Complementary Therapies. (Responded to review)
Fahimi F, Namdar R, Mousavi S, Ziaee S, Sharif-Kashani B, Tavalayee M, Baniasadi S. The first pharmacist based warfarin monitoring service in Iran. International Journal of Medicine and Medical Sciences. (Responded to review) Fahimi F, Sahraee Z, Amini S. Evaluation of Stat Orders in a Teaching Hospital. Clinical Drug Investigation. (Responded to review) Haj Hossein Talasaz A, Fahimi F, Jahangard Rafsanjani Z, Ziaie S. Drug utilization evaluation of human albumin in a teaching hospital. AIM. (Under review) Fahimi F, Kobarfard F, Salamzadeh J, Fakharian A, Abdollahi P, Talasaz A, Baniasadi S, Masjedi MR. The comparison between two common types of spacers in respiratory indices alteration (FEV1) and the bioavailability of albuterol using urine specimen of asthmatic patients in Masih Daneshvari Hospital. Journal of Aerosol Medicine and Pulmonary Drug Delivery. (Under review) Prepared manuscript for submission
Fahimi F, Soleymani F, Tavakoli M. Vancomycin utilization evaluation in a teaching hospital: A case- series study in Iran, Pharmacy Practice. Fahimi F, Ememi S, Rashid Farrokhi F. The rate of antibiotic dosage adjustment in renal dysfunction at a university hospital. Fahimi F, Adimi P, Naji SA, Naderi N, Morovvati S, Soleymani F, Masjedi MR. The evaluation of pharmacogenetic relationship of beta 2-adrenoceptors and response to salmeterol.
Fahimi F, Sharif-Kashani B, Hamraghani A, Salamzadeh J, Baniasadi S. NT-proBNP levels in COPD patients with secondary pulmonary hypertension receiving sildenafil or amlodipine.
Published Books:
1. Applied tables for physicians and pharmacists. 2. Questions and answers in asthma and COPD. 3. Questions and answers in tuberculosis, pneumonia, and swine flu. 4. What is warfarin? 5. Quick guide for preparation and administration of IV drugs in ICU. 6. Educational handbook on the medication of organ transplanted patients. 7. Drug and therapeutic committee. 8. Medication cessation before surgery. (In press)
• Selected Abstracts:
INTL-61 Citation: “Estimating the Precentage of Generic and Parenteral Medications Dispensed as Well as Missing Information on 5100 Prescriptions Filled at Community Pharmacies in Tehran. Fanak Fahimi, Bidjan Djahanguiri, Soha Namazi, and Aziz Delfan Dec., 2001, INTL-81 Citation: “Dosage Evaluation of Propranolol in Iranian Patients with Cardiovascular Diseases.” (Iran), Soha Namazi, Mojtaba Mojtahedzadeh, Fanak Fahimi, and Katayuon Kaviani Dec., 2001, International ASHP Congress, New Orleans, LA ,USA. “The correlation between Leptin & Fasting”, Oct. 10-12,2001, The Congress of Health & Ramadan, Tehran, Iran. “Leptin & obesity”, Oct. 5-9, 2001, 6th International Congress of Endocrine Disorders, Tehran, Iran. “The influence of education in children with ADHD & affective D/O on compliance their impovements” Aug. 27-29, 2002, 8th Iranian Seminar of Pharmaceutical Sciences,
Tehran, Iran. “Which is a better alternative? Study of 404 prescriptions from pharmacoeconomic point of view in Tehran”(lecture) Aug. 27-29, 2002, 8th Iranian Seminar of Pharmaceutical Sciences, Tehran, Iran. 1. “Metformin utilization review in Medical Center of Luisiana, June 2004” And 2. “A pilot study of commonly used drugs and its impact on economy: A cost minimization analysis.” March, 2005 10th European Association of Hospital Pharmacists (EAHP) Lisbon, Portugal 1. “Comparative efficacy of glycerin suppositories in the elderly with functional constipation.” And 2. “Transcription Errors Observed in a Teaching Hospital” And 3. “An Observational study in accuracy of infusion pumps implications and related admixture compatibility in an intensive care unit of a teaching hospital.” Oct. 2006, 35th European Symposium on Clinical Pharmacy (ESCP) Vienna, Austria. 1. Salamzadeh J, Fahimi F, Nematollahi M. “Evaluation of the utilization patterns of anti-
asthma medications at a university hospital. “ ELECTRONIC POSTER DISCUSSION And 2. Fahimi F, Salamzadeh J, Jamaati HR, Fakharian A, Sohrabi S, Mohammadtaheri Z. “Does atorvastatin have effect on lung function and morbidity as add-on therapy in asthmatic patients? ORAL PRESENTATION ERS Sep. 2007 Congress. Stockholm, Sweden.
Professional Affiliation:
Iranian Medical Council Organization Central ADR monitoring center committee (Ministry of Health) ADR news evaluation committee (Ministry of Health) DTC & Formulary Committee (Masih Daneshvari Hospital) Mortality Committee (Masih Daneshvari Hospital) Drug & Poison Information Center (Shahid Beheshti University of Medical Sciences) Position held: Clinical Pharmacy Board Secretary Head of the Pharmaceutical Care Department at Masih Daneshvari Hospital References:
• Available upon request. • http://www.sbmu.ac.ir/SiteDirectory/PharmacySchool/Pages/Facultymembers.aspx
• http://www.google.com/search?sourceid=navclient&ie=UTF-
8&rls=GGLR,GGLR:2006-46,GGLR:en&q=Fanak+Fahimi
• http://www.clinicalpharmacy.ir/default-58.aspx
The following is a list of the most commonly prescribed drugs. It represents an abbreviatedversion of the drug list (formulary) that is at the core of your prescription-drug benefit plan. The list is not all-inclusive and does not guarantee coverage. In addition to using this list,you are encouraged to ask your doctor to prescribe generic drugs whenever appropriate. PLEASE NOTE: The symbol * nex
Norfolk LSCB Protocol 20 Multi-agency Guideline for the Management of Sudden Unexpected Death in Infancy and Childhood Norfolk LSCB Protocol 20 CONTENTS Page No. Introduction Ambulance Staff Procedures and Guidance Procedures Guidance 6 Initial action at the scene (other than at A&E Dept) General Practitioners Procedures and Guidance
CURRICULUM VITAE